CLINICAL_TRIALS trial_result · 2014-08-22

Clinical Trial Update: Breakthrough Dyspnea Fentanyl Study in Cancer Patients [Phase 1, Phase 2]

A Phase 1/2 clinical trial assessed fentanyl for relief of breakthrough dyspnea in patients with advanced cancer; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Cancers, Dyspnea | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-08-22